Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine

Cell
|April 10, 1987
PubMed

Insights

Tyrosine phosphorylation regulates pp60c-src activity. Mutating tyrosine 527 activates the kinase, while mutating tyrosine 416 suppresses its function, revealing key regulatory mechanisms.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncogenesis

Background:

  • pp60c-src is a non-receptor tyrosine kinase.
  • Phosphorylation at tyrosine 527 (Tyr527) regulates pp60c-src activity in vivo.
  • Tyrosine 416 (Tyr416) is the site of in vitro autophosphorylation.

Purpose of the Study:

  • To investigate the role of Tyr527 and Tyr416 phosphorylation in regulating pp60c-src biological activity.
  • To determine how alterations in these tyrosine residues affect kinase and transforming activities.

Main Methods:

  • Construction and study of pp60c-src mutants with Tyr527 and Tyr416 altered to phenylalanine.
  • Assay of transforming and kinase activities of wild-type and mutant pp60c-src proteins.

Main Results:

  • Mutation of Tyr527 to phenylalanine (Tyr527Phe) strongly activated pp60c-src transforming and kinase activities.
  • The additional introduction of a Tyr416 to phenylalanine mutation (Tyr527Phe/Tyr416Phe) suppressed these activated activities.
  • Mutation of Tyr416 to phenylalanine in normal pp60c-src eliminated its partial transforming activity.

Conclusions:

  • Tyrosine phosphorylation at Tyr527 is a critical negative regulator of pp60c-src.
  • Phosphorylation at Tyr416 plays a role in pp60c-src function, potentially through transient or restricted phosphorylation.
  • These findings elucidate the regulatory mechanisms governing pp60c-src activity and its role in cellular processes.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...